A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants

Summary

The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-005 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP-005 and Part 2, multiple ascending dose (MAD).

Timeline

Start

2023-11-23

Primary completion

2024-08-31

Completion

2024-08-31

Drugs

Indications